newsfilter
← Latest News
Business Wire·

Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation

SEC declines to impose civil penalties in light of the Company's self-reporting, prompt remediation and cooperation Kiromic BioPharma, Inc. (OTCQB:KRBP) ("Kiromic" or the "Company") today announced that it has entered